SciELO - Scientific Electronic Library Online

 
 issue41Scintigraphy with -MIBI in the assessment and the prediction of multidrug resistance in patients with lymphoma author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Nucleus

Print version ISSN 0864-084X

Abstract

BECKFORD VERA, Denis R. et al. New radioimmunoconjugate -dota-h-r3: synthesis and radiolabeling. Nucleus [online]. 2007, n.41, pp. 3-12. ISSN 0864-084X.

Labelling of monoclonal antibodies with radioactive metals for cancer diagnosis and therapy has usually been accomplished by the use of bifunctional chelating agents, which contain both a reactive functionality for covalent attachment to proteins and a strong metal-binding group capable of forming a physiologically stable complex with the radionuclide. The objective of the present work was to modify the humanized monoclonal antibody (h-R3) with the 1,4,7,10-tetraaza-cyclododecane N,N´,N´´,N´´´-tetraacetic acid (DOTA) in aqueous solution, achieve the labelling of the obtained conjugates with and study some of the variables that influence in the labelling reaction, as well as the stability of the radioimmunoconjugate in presence of other chelating agents.

Keywords : monoclonal antibodies; diagnosis; neoplasms; labelled compounds; yttrium 90.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )